Introduction
Dopamine receptor sensitivity and selectivity are modulated by the magnitude and duration of synaptic dopamine concentrations. Prolonged elevation of synaptic dopamine produces receptor desensitization (Cho et al., 2006; Memo et al., 1982) , whereas persistent reduction of synaptic dopamine can lead to the development of postsynaptic dopamine receptor supersensitivity (Gerfen, 2003; Henry and White, 1991; Klawans et al., 1975; Mishra et al., 1974) . While numerous studies have documented dramatic changes in dopaminergic function as a consequence of experimental or disease-induced dopamine imbalance in the brain (Anderson and Pierce, 2005; Berthet et al., 2009; Guigoni et al., 2007; McGinty et al., 2008; Stanwood and Levitt, 2007) , the mechanisms underlying such changes do not always involve changes in cell-surface receptor expression. To explain how function may change without a change in receptor number, some propositions have been advanced, including the mobilization of extrasynaptic receptors (Balfour et al., 2000; Korf and Loopuijt, 1988; Paspalas and Goldman-Rakic, 2004) as well as receptor internalization or receptor phosphorylation. More recently, receptor trafficking via signaling endosomes (Hanyaloglu and von Zastrow, 2008; Sadowski et al., 2009) , receptor heterodimerization (Agnati et al., 2003; Lee et al., 2004; Lee et al., 2000; Pin et al., 2007) , and plasma membrane receptor segregation across lipid rafts (Ostrom and Insel, 2004) have been explored as novel mechanisms that modulate dopamine or other G protein-coupled receptor signaling.
The association of diverse receptors with lipid rafts -specialized nanoscale assemblies of cholesterol, sphingolipid and proteins -has raised the speculation that dopamine receptor subtypes may be differentially distributed within and outside these specialized structures, and that such distribution may have relevance to the pharmacology of this catecholamine. While it is clear from receptor trafficking experiments that synaptic dopamine concentration drives the subcellular location or endosomal transport of dopamine receptors (Dumartin et al., 1998;  4 Dumartin et al., 2000; He et al., 2009; Sun et al., 2003) , it is still unknown if transmitter concentrations or exposure duration might influence the intra-membrane distribution of specific receptor subtypes, and how such influences may relate to physicochemical or functional receptor interactions or chronic alterations in receptor function.
In this study we used differential detergent solubilization and gradient centrifugation with subsequent immunodetection to examine dopamine receptor subtype localization in rat cortical tissues under basal conditions. We also induced alterations in synaptic dopamine activity via repeated administration of cocaine, and then re-examined the receptor subtype distribution profiles among the subcellular compartments. Since distinct signaling molecules can be enriched in specific subcellular compartments or plasma membrane subdomains, we tested the hypothesis that the intensity and duration of synaptic dopamine can drive dopamine receptor redistribution and thus direct the nature of receptor coupling to signal transduction cascades.
Results

Distribution of dopamine receptor subtypes among subcellular compartments
Previous ligand-binding studies by our group and others suggested that dopamine receptor oligomerization and function can be modulated by exposure to reducing agents (Panchalingam and Undie, 2005; Sidhu, 1990; Sidhu et al., 1994) . In the present study, we used rat cerebrocortical slices prepared through a process that was identical to conditions used in the prior functional studies examining various aspects of dopamine receptor-mediated biological activities (Panchalingam and Undie, 2005; Sidhu, 1990; Sidhu et al., 1994) . Inclusion of a reducing agent (β-mercaptoethanol or dithiothreitol) in the sample loading buffer was essential for visualization of monomeric and dimeric forms of the D 1 subtype (Fig. 1A) . The D 1 receptors (~66kDa) were predominantly located in the detergent-resistant membrane (DRM) fraction, at more than 20 times the concentration found in the detergent-soluble membrane (DSM) fraction.
FIGURE 1 HERE
Under reducing conditions, the majority of D 5 receptor immunoreactivity was observed as monomers in the cytoplasmic fraction with significantly less receptor protein in the DSM fraction; D 5 receptors were undetectable in the cortical DRM fraction (Fig 1C) . A monoclonal D 1B (D 5 ) receptor antibody also exhibited greatest immunoreactivity in the cytoplasmic fraction ( Fig   1G) . The D 2 receptor monomer (~55kDa) was observed predominantly in the DSM fraction, with less localized to the DRM fraction ( Fig 1E) . Under these conditions, where 20 µg of protein extract was loaded per lane, no D 2 receptor immunoreactivity was detected in the cytoplasmic fraction. Nevertheless, the cytoplasmic D2 receptors appeared to be labile, with respect to cellular localization ( Supp Fig 2) . A correlation existed between the rapidity with which the tissue was removed and processed, and the ability to observe D2 receptors in the cytoplasmic fraction.
Likewise, the duration of slice incubation was correlated with the ability to visualize D2 receptors in the cytoplasmic compartment. Finally, the data shown in Figure 1 were derived from membranes solubilized with 1% Triton X-100; however, the results were identical when 1% deoxycholate was used as the solubilizing agent (deoxycholate data not shown).
Under non-reducing conditions the D 1 receptor resisted solubilization as evidenced by the absence of immunoreactivity on Western blots. This observation was interpreted as support for the formation of a protein complex that was either too large or too insoluble to enter the gel matrix, resulting in the lack of detectable D 1 receptor signal on Western blots (Fig 1B) . This contrasted with the D 5 and D 2 receptors, where monomeric and oligomeric forms could readily be discerned under non-reducing conditions in the DSM and cytoplasmic fractions (Fig 1D, 1F ).
The strength of association of the non-migrating D 1 receptor complexes was tested by exposing DRMs to urea or potassium iodide -reagents that can disrupt hydrophobic protein-protein 6 interactions (Brady et al., 2004) . Neither denaturant was capable of dissociating D 1 receptors from the insoluble complexes, indicating that the association was probably of a covalent nature (data not shown).
To determine the specificity of the dopamine receptor antibodies used in this study, extracts from HEK293 cells expressing D 2L receptors, and Sf9 cells expressing either D 2L or D 3 receptors were screened by Western blot. The Santa Cruz D 2 receptor antibody elicited immunoreactivity only in cells that were transfected with D 2L , but not D 3 receptor (Supp. Fig 1A, B). The specificity of the rabbit polyclonal D 5 receptor antibody was demonstrated by comparing the immunoreactive profile of mouse hippocampal and liver tissue extracts. Immunoreactive proteins with molecular weights similar to that seen in rat cortex and striatum were observed in hippocampal, but not liver, extracts (Supp. Fig 1C) ; these observations correspond to previously published reports (Bergson et al., 1995; Luedtke et al., 1999) . Blots were reprobed with β-actin to confirm equal loading of protein. Vascular tissue extracts (Cy, DSM, DRM) are shown to emphasize that β-actin comprises a smaller percentage of total protein in the DSM compared to cytoplasm and DRM, as noted in hipocampal and liver extracts (Supp Fig 1D) .
We next sought to characterize the cytoplasmic, DSM and DRM fractions by reprobing blots with antibodies for Rap1, G olf , G i1 , Gq/ 11 and PLCβ1 -dopamine receptor-related signaling components whose subcellular localization has previously been characterized (Canobbio et al., 2008; Donati and Rasenick, 2005; Kelly et al., 2005) . Rap1, G olf , Gq/ 11 , G i1 and PLCβ1 were all found in the DSM (Fig 2) . Rap1 was the only protein tested that was not detected in DRM fractions; PLCβ1 was the only molecule detected in the cytoplasmic fraction. The non-receptor tyrosine kinases Src and Fyn have not been linked to direct activation by dopamine receptors, but have been found in both DSM and DRM (Patra, 2008; Yasuda et al., 2002) . Src and Fyn were present in nearly equal amounts in both the DSM and DRM (Fig 2) . Notably, Fyn, but not Src, was also found in the cytoplasmic fraction. The metabotropic glutamate receptor 5 (mGluR5) is another G protein-coupled receptor that was not expected to be present in the cytoplasmic fraction, and indeed was found to localize exclusively to DSM and DRM fractions (Fig 2) .
FIGURE 2 HERE
Dopamine receptor localization among cellular subdomains
In order to further characterize the DRM in which the D 1 receptor was predominantly located, subcellular fractionation was carried out, adding a detergent step to separate DSM from DRM in each fraction. In these experiments, extracts were prepared from acutely isolated rat prefrontal cortex tissues. The data revealed that the D 1 receptor was consistently localized to the DRM fraction, while residual amounts of the receptor could be detected in membrane subfractions sedimenting at each tested centrifugation step, including the 300,000g step ( Fig   3A) . The D 5 receptor was again found primarily in the cytoplasmic fraction comprised of the supernatant from centrifugation at 300,000g (Fig 3B) .
FIGURE 3 HERE
In the case of the D 2 receptor, the plasma membrane was the predominant fraction in which the receptor was found, with approximately equal distribution between DSM and DRM ( Fig 3C) . The remaining minor component of D 2 receptors was distributed between the synaptosomal, microsomal and ribosomal membrane fractions. Interestingly, the ratio of D 2 receptor in DSM and DRM was variable among these substructures. Synaptosomal DSM contained more of the D 2 receptor than synaptosomal DRM, whereas for microsomal and ribosomal membranes the D 2 receptor tended to locate more in the DRM fraction than the DSM. In this experiment and in the density gradient experiments, cross-reacting proteins of 60 -70kDa were noted in the cytoplasmic fraction. These species have been described in the past as representing differing extents of glycosylation of the D2 receptor (Fishburn et al., 1995) . Consistently, the predominant D 2 receptor band was that which possessed a relative migration of approximately 55kDa. In these analyses, the controls included PSD95, which is detected only in the synaptosomal DRM 8 fraction (Fig 3D) , and calnexin, which is enriched in the microsomal fraction, but can also be observed in the synaptosomal fraction (Archibald et al., 1999) (Fig 3E) .
Dopamine receptors display distinct buoyancies in sucrose gradients
To further explore the idea that dopamine receptor subtypes partition differentially into membrane fractions within the cell, we carried out discontinuous sucrose density gradient fractionation using acutely isolated cortical membranes. This method has been used to isolate membrane subdomains that have distinct biochemical compositions or properties, such as lipid rafts and caveolae. We found a significant proportion of D 1 receptors in buoyant membranes (Fig 4A) , in fractions where flotillin ( Fig 4D) and caveolin ( Fig 4E) are observed. D 1 receptors were distributed throughout the lower portion of the gradient, including the insoluble pellet ( Fig   4A) . As predicted, PSD95 was restricted to the insoluble pellet ( Fig 4F) . Similar to what was observed in the crude fractionation experiments, the D 5 receptors preferentially partitioned into the cytoplasmic phase while D2 receptors were found both in the cytoplasmic and membrane fractions. Neither the D 2 nor the D 5 receptor was present in any significant amount in buoyant membranes where flotillin, caveolin and D 1 receptors were found (Fig 4B, 4C ). (Fig 5B, 5C ). To control for equivalent sample loading, blots were reprobed with β3-tubulin (Fig 5D) , α-synuclein ( Fig 5E) and PSD-95 (Fig, 5F ). While β3-tubulin and α-synuclein were abundant in cytoplasmic and DSM membranes, and PSD-95 was observed solely in the DRM fraction, chronic cocaine administration did not alter the content or localization of any of these control proteins.
FIGURE 5 HERE
Striatal tissue from these same animals also was fractionated and assessed for changes in D 1 , D 5 , and D 2 receptor distribution (Fig 6) . Basal distribution of the receptors and subcellular markers in the saline-treated animals was similar to the distribution in naïve cortical tissue.
Contrary to the observations in the frontal cortex, however, cocaine treatment failed to induce any significant redistribution of the dopamine receptor subtypes in the striatum. 
Localization of dopamine receptors in cortex
D 1 receptors were preferentially localized to detergent-resistant brain membranes. Such membrane subdomains that are resistant to solubilization in cold Triton X-100 include postsynaptic densities, lipid rafts and caveolae. Thus, the present observations correlate with published reports of direct D 1 receptor interactions with NMDA receptors, PSD-95 or caveolin-1 -proteins that are known to reside in detergent-resistant subdomains or lipid rafts (Fiorentini et al., 2003; Kong et al., 2007; Lee et al., 2002; Pei et al., 2004; Zhang et al., 2007) . Consistent with previous reports that D 1 receptors resist solubilization in the absence of a reducing agent (Bergson et al., 1995; Sidhu, 1990) , we found that disulfide bond disruption with β-mercaptoethanol or DTT was essential to visualize D 1 receptor monomers and dimers by Western analysis. This was intriguing as it implies that D 1 receptors form covalently associated multimers (or the multimers may be covalently associated with some other membrane proteins). This inference is supported by the frequent observation of residual high molecular weight material on PAGE blots that reacts strongly with D 1 receptor antibodies but fails to dislodge or migrate through the gel. The size of this residual complex was reduced in samples treated with reducing agent (data not shown). It was, however, unperturbed by treatment with strong denaturants such as urea or potassium iodide which effectively disrupt hydrophobic proteinprotein interactions.
Inclusion of the cytoplasm for analysis was originally intended only as a control, as it was assumed that G protein-coupled receptors would ordinarily not reside to any appreciable extent in a cytoplasmic fraction. Nevertheless, D 5 receptors were reproducibly and predominantly detected in the cytoplasm (200,000-300,000g supernatant), an observation that was further confirmed with a monoclonal D 5 receptor antibody. This characteristic distribution distinguishes the D 5 from D 1 receptors (Bergson et al., 1995) . D 5 receptors were typically detected as a predominant band of approximately 50kD, with a second band at approximately 45kD.
Previously published reports demonstrated that treatment of membrane extracts with deglycosylating enzymes caused the approximately 50kD D 5 receptor band to migrate with the 45kD marker (Bergson et al., 1995; Karpa et al., 1999) , thus we postulate that the 45kD protein represents the deglycosylated form of the receptor. The nature of the approximately 66kD cytoplasmic protein detected with mouse anti-D 5 receptor antibody has not been determined ( Figure 1G ). Previously published immunohistochemical analyses of D 5 receptors in brain indicated that this receptor was present primarily in the somal cytoplasm in tissues where the receptor was expressed (Ariano et al., 1997; Bergson et al., 1995; Ciliax et al., 2000; Khan et al., 2000; Oda et al.) . Similarly, in cultured cells D 1 receptors were localized to the plasma membrane, whereas D 5 receptor immunoreactivity was high in the somal cytoplasm and also present on the cell surface (He et al., 2009 ). The present determination that D 5 receptors do not sediment at 300,000g suggests that these receptors are associated with a microvesicular membrane of high lipid content, rendering it difficult to sediment. Evidence for such microvesicles exists primarily in plants (Yao et al., 1991) , although evidence for phospholipase C/phosphatidic acid-containing vesicles that resist sedimentation also exists in mammalian cells (Olsen et al., 1993) . The recent finding that D 5 receptors mediate stimulation of phosphoinositide signaling as well as CDP-diacylglycerol synthesis from phosphatidic acid (Sahu et al., 2009) , together with the current finding of cytoplasmic localization of D 5 receptors and PLCβ1, would be consistent with a preferential distribution of the receptors to sedimentation-resistant phospholipase C/phosphatidic acid-containing microvesicles. distribution was rather labile as the compartmental proportions varied with conditions such as exposure to reducing agent or whether membranes had been freshly isolated from tissue or from slices pre-equilibrated ex vivo for 45 min (Lee et al., 2000) . For example, D 2 receptors were more frequently observed in the cytoplasm when extracts were rapidly obtained from acutely isolated cortical tissue, but were almost completely redistributed into the membrane fraction after slices were equilibrated by incubation in oxygenated HEPES-bicarbonate buffer at Fig 2) . Hence, D 2 receptor localization is dynamic, shifting between compartments in response to conditions in the cellular environment. We hypothesize that the shifting of D2 receptors between compartments represents a biological phenomenon that reflects synaptic levels of neurotransmitter. Interestingly, it is well understood by electrophysiologists using the acute brain slice preparation that slices typically require a period of recovery, generally one hour post-processing. The data we present here may well provide a biological explanation for the need to re-equilibrate slices ex-vivo prior to initiation of electrophysiological analyses: the equilibration incubation allows for repositioning of the receptors in appropriate compartments for subsequent action. This is also consistent with existing evidence for alterations in D 2 receptor function as a consequence of tissue handling (Vazquez et al., 2007) . (Kong et al., 2007; Yu et al., 2004) . D 1 receptors were also found in the pellet at the bottom of the gradient, where membranes resistant to solubilization with 1% TX-100 are found, and where post-synaptic density proteins are located. D 1 receptor co-localization with synaptosomal proteins was also noted in detergent-resistant synaptosomal membranes (Fig. 4) . Distribution of D 1 receptors within these substructures is consistent with studies concluding that D 1 receptor interactions with NMDA receptors or PSD-95 influence D 1 receptor function (Fiorentini et al., 2003; Pei et al., 2004; Zhang et al., 2007) . The observation that D 1 receptors were found throughout the sucrose gradients may reflect an ability of the receptors to associate with diverse membranous structures in different cellular compartments (Vickery and von Zastrow, 1999) , each perhaps characterized by distinct lipid compositions. The results of differential centrifugation support this, since D 1 receptors were nearly equally distributed in DRM throughout the cell.
Synaptic dopamine drives receptor localization
Lipid rafts are biochemically distinct membrane subdomains theoretically providing flexibility and efficiency in signal transduction by segregating related signaling mediators. A hallmark of lipid rafts is the physicochemical segregation of cellular mediators that specify the coupling mechanisms for receptor-mediated signaling (Hancock, 2006; Harding and Hancock, 2008; Ostrom and Insel, 2004) . For example, translocation of G-proteins and other signaling molecules into and out of rafts aids in directing cellular responses to specific agonist stimulation (Allen et al., 2007; Head et al., 2006; Patel et al., 2008) 
Experimental methods
Animals
Male Sprague-Dawley rats weighing 250-275g were purchased from Zivic Laboratories, Pittsburg, PA. The animals were caged in groups of three and housed in climate-controlled facilities with a 12-h light/dark cycle and free access to food and water. Protocols for the care and use of the experimental animals were approved by the Institutional Animal Care and Use Committee and conformed to the principles set forth in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Materials
Cocaine hydrochloride was obtained from the National Institute on Drug Abuse, Bethesda, MD.
All other reagents, including a protein inhibitor cocktail comprising 4-(2-aminoethyl) benzenesulfonyl fluoride, E-64, bestatin, leupeptin and aprotinin, were obtained from SigmaAldrich (St. Louis, MO).
Cocaine administration
Rats were administered intraperitoneal (i.p.) injections of either 0.9% sterile saline as control or 20 mg/kg cocaine dissolved in 0.9% sterile saline. Injections were administered to the animals in their home cage, and repeated once each day for seven days. Animals were euthanized 24 h after the last injection. Brains were quickly removed and frontal cortical tissues were dissected out as previously described (Undie and Friedman, 1990) .
Preparation of tissue slices
Dissected cortices were chopped into 350 x 350 µm slices using a McIlwain tissue chopper.
Slices were washed three times in 20 volumes of HEPES-bicarbonate buffer containing, in mM: NaCl 122, KCl 4.9, KH 2 PO 4 1.2, MgCl 2 1.2, NaHCO 3 36, HEPES 30 and glucose 10. The suspension was aerated with 95% O 2 /5% CO 2 and incubated for 15 min at 37 °C with continuous reciprocal shaking. The buffer was then exchanged by washing three times with HEPES bicarbonate buffer that contained 1.2 mM CaCl and slices were equilibrated in a fresh aliquot of the buffer for an additional 45 min. Following a brief low-speed centrifugation, excess buffer was removed to obtain a slurry of packed slices (Undie and Friedman, 1990) .
Isolation of cytoplasmic and membrane fractions
Tissue from one rat was collected into 1 ml of homogenization buffer comprised of 10 mM HEPES, pH 7.4, 2 mM EDTA, 320 mM sucrose and 2% (v/v) protease inhibitor cocktail. The material was transferred to a glass/Teflon homogenizer and homogenized gently on ice with 18-20 strokes. The homogenate was centrifuged at 1000g for 10 min to pellet nuclei and cellular debris (P1 fraction). The supernatant (S1) was reserved and the P1 pellet was washed with 1 ml of homogenization buffer and centrifuged again at 1000g for 5 min. The pooled supernatants were centrifuged for 5 min at 1000g to remove residual debris. This post-nuclear fraction was then centrifuged for 45 min at 200,000g. The supernatant (S2) corresponding to a crude cytoplasmic fraction was saved; the crude membrane pellet (P2) was washed in 1 ml of membrane buffer (25 mM HEPES, pH 7.4, 2 mM EDTA and protease inhibitors) and both the cytoplasmic and membrane fractions were centrifuged again at 200,000g for 30 min. The cytoplasmic fraction was saved for further analysis. The P2 pellet was resuspended in membrane buffer and homogenized with 8-10 strokes on ice. To solubilize membranes, Triton X-100 (or sodium deoxycholate as indicated) was added to a final concentration of 1% and the extracts were incubated overnight at 4°C. Membranes were subsequently centrifuged at 200,000g for 45 min. The supernatant (S3) from this step was retained as the DSM fraction. The pellet (P3) comprised the DRM fraction. The DRM pellet was washed with membrane buffer, recovered by centrifugation at 200,000g for 30 min, and then resuspended in membrane buffer containing 1% Triton X-100. The DSM fraction was further cleared by centrifugation at 200,000 g for 30 min, retaining the supernatant for subsequent analyses.
In some experiments, differential centrifugation was used to obtain a mitochondrial fraction (12,500g, 15 min), plasma membrane (23,000g, 30 min), microsomal membrane (100,000g, 1.5h), and ribosomal membrane fractions (300,000g, 2h). Synaptosomes were enriched from the mitochondrial fraction by separation over a discontinuous sucrose gradient.
The gradient was formed by layering 2.4ml of 1.2M sucrose in the bottom of a 13 ml tube, followed by a layer of 7.2ml of 0.8M sucrose. The mitochondrial/synaptosomal pellet was resuspended in 2.4ml of 0.3M sucrose and layered on top of the 0.8M sucrose layer. Gradients were centrifuged at 54,000g for 2h. The synaptosomal layer was collected from the interface between 1.2 and 0.8M sucrose and centrifuged at 100,000g for 1 h in order to pellet synaptosomal membranes. Triton X-100-soluble and resistant synaptosomal fractions were isolated as described above by pretreating the sample with 1% Triton X-100 followed by centrifugation at 200,000g for 30 min.
Sucrose gradient ultra-centrifugation and TCA precipitation
All manipulations were carried out on ice or at 4°C. Cortical tissues were isolated from three animals and the tissues pooled for processing in order to recover sufficient amounts of DRM material for analysis. The cytoplasmic and P2 membrane fractions were isolated as described above. The P2 membrane pellet was resuspended in 0.9 ml of MES buffered saline (MBS; comprised of 40 mM MES, pH 6.5, 150 mM NaCl, 2% protease inhibitors) and homogenized 8-10 strokes on ice. Triton X-100 was added to a final concentration of 1%. Membranes were mixed 1:1 with 85% sucrose in MBS, placed in the bottom of a 13 ml polyallomer tube and carefully overlaid with 6 ml of cold 35% sucrose/MBS followed by 4 ml of 5% sucrose/MBS using a 22 G syringe. The gradients were centrifuged for 19 h at 182,000g and 4°C in an SW40Ti rotor (Beckman-Coulter). Fractions (1ml) were gently collected from the top of the gradient (from Fraction #1 at the top to Fraction #12 at the bottom). Each pellet was resuspended in 0.5 ml MBS and mixed with an equal volume of 85% sucrose.
Cold 100% trichloroacetic acid (TCA) was added to each fraction such that the final concentration was 20%. Samples were kept on ice for 15 min and then centrifuged at 22,500g and 4°C for 15 min. Samples were immediately placed on ice, and the clear upper layer was removed leaving the cloudy lower layer. To each sample, 700µl of acetone was added and tubes were centrifuged for 10 min at 22,500g. Acetone was removed and samples were dried overnight in a fume hood. To resuspend, 250µl of 20 mM Tris, pH 8.0 was added to each sample, followed by trituration with 8 strokes of a glass/Teflon homogenizer. Triton X-100 was added to a final concentration of 1%, and fractions were subsequently analyzed by Western blotting.
Dopamine receptor antibody specificity
Cell lysates from Sf9 cells were a generous gift from R.R. 
Protein quantitation and Western blot analysis
Sample aliquots were taken for quantitation of protein using the Pierce BCA protein assay kit the distribution of loading controls was not equivalent across the three compartments examined (cytoplasmic, DSM, DRM). This critical issue has been addressed recently (Aldridge et al., 2008) . Chemiluminescence images were collected onto Kodak Blue XB-1 film, and subsequently scanned and quantitated by densitometry using ImageQuant (v. 1.2, Molecular Dynamics).
Data analysis
Quantitative data are expressed as mean+/-SEM. Statistical analysis was conducted using one-way analysis of variance (ANOVA), followed by a post-hoc Bonferroni-Dunnett test (Statview).
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